AR083379A1 - Mecanismo de establecimiento de dosis y metodo para utilizar el mismo - Google Patents

Mecanismo de establecimiento de dosis y metodo para utilizar el mismo

Info

Publication number
AR083379A1
AR083379A1 ARP110103748A ARP110103748A AR083379A1 AR 083379 A1 AR083379 A1 AR 083379A1 AR P110103748 A ARP110103748 A AR P110103748A AR P110103748 A ARP110103748 A AR P110103748A AR 083379 A1 AR083379 A1 AR 083379A1
Authority
AR
Argentina
Prior art keywords
dose
clutch
housing
establishment
administration
Prior art date
Application number
ARP110103748A
Other languages
English (en)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of AR083379A1 publication Critical patent/AR083379A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31525—Dosing
    • A61M5/31528—Dosing by means of rotational movements, e.g. screw-thread mechanisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31525—Dosing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A61M5/31535—Means improving security or handling thereof, e.g. blocking means, means preventing insufficient dosing, means allowing correction of overset dose
    • A61M5/31536—Blocking means to immobilize a selected dose, e.g. to administer equal doses
    • A61M5/31538—Permanent blocking, e.g. by medical personnel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A61M5/31545—Setting modes for dosing
    • A61M5/31548—Mechanically operated dose setting member
    • A61M5/3155—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
    • A61M5/31551—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe including axial movement of dose setting member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
    • A61M5/31583—Constructional features or modes of drive mechanisms for piston rods based on rotational translation, i.e. movement of piston rod is caused by relative rotation between the user activated actuator and the piston rod
    • A61M5/31585—Constructional features or modes of drive mechanisms for piston rods based on rotational translation, i.e. movement of piston rod is caused by relative rotation between the user activated actuator and the piston rod performed by axially moving actuator, e.g. an injection button
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • A61M5/31566—Means improving security or handling thereof
    • A61M5/31571—Means preventing accidental administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La presente solicitud se refiere a un mecanismo de establecimiento de dosis para un dispositivo de administración de dosis y a un método para utilizar el mismo. El mecanismo comprende un alojamiento (17) de dispositivo de administración de fármacos, un casquillo (9) de selección de dosis situado por lo menos parcialmente en el alojamiento (17) y que es giratorio durante el establecimiento de la dosis y la administración de la dosis, un embrague (13) giratorio durante el establecimiento de la dosis y no giratorio durante la administración de la dosis, y una tuerca (15) de embrague, que se acopla de manera roscada con el embrague (13) y se une con estrías al alojamiento (17) para evitar el giro de la tuerca (15) de embrague.
ARP110103748A 2010-10-13 2011-10-11 Mecanismo de establecimiento de dosis y metodo para utilizar el mismo AR083379A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39274910P 2010-10-13 2010-10-13
EP11168189 2011-05-31

Publications (1)

Publication Number Publication Date
AR083379A1 true AR083379A1 (es) 2013-02-21

Family

ID=44785857

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110103748A AR083379A1 (es) 2010-10-13 2011-10-11 Mecanismo de establecimiento de dosis y metodo para utilizar el mismo

Country Status (11)

Country Link
US (1) US9707351B2 (es)
EP (1) EP2627379B1 (es)
JP (1) JP5823525B2 (es)
CN (1) CN103260676B (es)
AR (1) AR083379A1 (es)
AU (1) AU2011315625B2 (es)
BR (1) BR112013008872A2 (es)
CA (1) CA2814080A1 (es)
IL (1) IL225677A (es)
TW (1) TWI554300B (es)
WO (1) WO2012049140A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201905362T4 (tr) * 2013-07-17 2019-05-21 Sanofi Sa İlaç dağıtım cihazı.
US10478565B2 (en) 2013-11-15 2019-11-19 Sanofi-Aventis Deutschland Gmbh Assembly for a drug delivery device and drug delivery device
CN107206178B (zh) * 2014-11-24 2020-11-10 赛诺菲 剂量设定机构和具有棘轮机构的药物输送装置
WO2016128425A1 (en) * 2015-02-10 2016-08-18 Sanofi-Aventis Deutschland Gmbh Drive mechanism for an injection device
US10293113B2 (en) 2015-02-10 2019-05-21 Sanofi-Aventis Deutschland Gmbh Drive mechanism for an injection device
EP3181171A1 (en) * 2015-12-14 2017-06-21 Sanofi-Aventis Deutschland GmbH Drive mechanism for an injection device
EP3181169A1 (en) * 2015-12-14 2017-06-21 Sanofi-Aventis Deutschland GmbH Drive mechanism for an injection device
US10709845B2 (en) 2016-07-21 2020-07-14 Amgen Inc. Drug delivery device with a rotatable drive mechanism
CN112955198B (zh) * 2018-10-30 2023-07-28 诺和诺德股份有限公司 扭转弹簧驱动式注射装置
WO2023203040A1 (en) 2022-04-21 2023-10-26 Sanofi Drive mechanism for an injection device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3715258C2 (de) * 1987-05-08 1996-10-31 Haselmeier Wilhelm Fa Injektionsgerät
DK175491D0 (da) * 1991-10-18 1991-10-18 Novo Nordisk As Apparat
DE20209051U1 (de) * 2001-12-21 2003-04-24 Disetronic Licensing Ag Injektionsgerät mit endpositionsblockiertem Dosiseinstellglied
AT413719B8 (de) * 2002-09-02 2006-06-15 Lafarge Roofing Components Vorrichtung für die in-dach-verbindung von wenigstens zwei plattenförmigen bauteilen auf einem schrägdach
EP2210634A1 (en) * 2009-01-22 2010-07-28 Sanofi-Aventis Deutschland GmbH Drug delivery device dose setting mechanism
GB0304822D0 (en) 2003-03-03 2003-04-09 Dca Internat Ltd Improvements in and relating to a pen-type injector
EP2047878B1 (en) * 2004-12-01 2011-02-23 Novo Nordisk A/S Injection Device
US8647309B2 (en) * 2008-05-02 2014-02-11 Sanofi-Aventis Deutschland Gmbh Medication delivery device

Also Published As

Publication number Publication date
TW201219078A (en) 2012-05-16
WO2012049140A1 (en) 2012-04-19
TWI554300B (zh) 2016-10-21
AU2011315625B2 (en) 2016-01-14
JP5823525B2 (ja) 2015-11-25
CN103260676A (zh) 2013-08-21
CN103260676B (zh) 2016-01-20
AU2011315625A1 (en) 2013-04-11
EP2627379A1 (en) 2013-08-21
IL225677A (en) 2017-07-31
CA2814080A1 (en) 2012-04-19
BR112013008872A2 (pt) 2017-07-11
IL225677A0 (en) 2013-06-27
US20130197478A1 (en) 2013-08-01
US9707351B2 (en) 2017-07-18
JP2013539696A (ja) 2013-10-28
EP2627379B1 (en) 2019-05-01

Similar Documents

Publication Publication Date Title
AR083379A1 (es) Mecanismo de establecimiento de dosis y metodo para utilizar el mismo
AR083386A1 (es) Mecanismo de establecimiento de dosis y metodo para establecer una dosis
CL2012000319A1 (es) Uso de una composición farmaceutica que comprende treprostinil para la preparación de un medicamento para el tratamiento o la prevención de una afección asociada a la fibrosis quística.
CL2009000173A1 (es) Compuestos derivados de urea-tetrahidroxiquinoxalina; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso para el tratamiento y la prevencion de la obesidad y la diabetes, resistencia a la insulina, sindrome metabolico, entre otros.
ECSP13012661A (es) Composición farmacéutica, métodos de tratamiento y usos de la misma.
ES2445846R1 (es) Una composición de combinación farmacéutica y su uso para preparar un medicamento destinado al tatamiento de la diabetes de tipo l y los trastornos metabólicos
CL2014001450A1 (es) Forma de dosis de liberacion controlada solida que comprende un analgesico opioide dispersado en un material de matriz; metodo de preparacion; uso en el tratamiento del dolor.
CL2013001558A1 (es) El uso de compuestos moduladores o agonistas de los receptores de s1p para disminuir la frecuencia cardiaca en aproximadamente 2 latidos/minuto; metodo para aminorar, prevenir o limitar un efecto cronotropico negativo; un kit farmaceutico.
GT201200144A (es) Composición farmacéutica que comprende un agonista de glp-1, una insulina y metionina
GT201200020A (es) Composición de insulina de acción prolongada
CL2015001923A1 (es) Uso de crenolanib para el tratamiento de trastornos proliferativos que tiene flt3 mutado
BR112015009189A2 (pt) conjunto de potência para um autoinjetor e autoinjetor que contém o mesmo
CL2012002356A1 (es) Compuestos heterociclicos acidos derivados de ariltriazolonas ligadas a bisarilo, inhibidores de receptores de vasopresina v1a y v2; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar y/o prevenir insuficiencia cardiaca aguda y cronica, hiponatremia, entre otras.
CL2011000774A1 (es) Formulacion farmaceutica que comprende el compuesto 4-[3-(4-ciclopropanocarbonil-piperazina-1-carbonil)-4-fluorobencil]-2h-ftalazin-1-ona en dispersion solida con un polimero de matriz; correspondiente a copovidona, util en el tratamiento del cancer.
BR112013024060A2 (pt) dispositivo de distribuição de fármacos com tampa protetora giratória
UY30056A1 (es) Administracion transdermica de meptazinol
AR060880A1 (es) Uso de flibanserina para el tratamiento de trastornos posmenopausicos del deseo sexual
AR065392A1 (es) Metodos para el tratamiento por inhalacion de una enfermedad o estado respiratorio
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
ECSP11011294A (es) Compuestos de anillo fusionados y su uso
BR112013024973A2 (pt) prevenção de hipoglicemia em pacientes com diabetes mellitus do tipo 2
CL2015001610A1 (es) Compuestos derivados de pirimido-[4,5-b]-quinolina-4,5(3h,10h)-dionas para utilizarse como un medicamento para el tratamiento de una enfermedad causada por una mutacion sin sentido; composicion y combinacion farmaceutica que los comprende.
AR091351A1 (es) Formulaciones de bromocriptina, metodo para mejorar el control glucemico y metodo para la fabricacion
CL2009000803A1 (es) Uso de una variante de igf-1 pegilada para tratar, prevenir un trastorno neuromuscular; metodo para el tratamiento, prevencion y/o demora de un trastorno neuromuscular; composicion que comprende la variante de igf-1 modificada
CR20140005A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee